Lu L - Search Results

1

Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1.

Liu B, Zhang W, Xia B, Jing S, Du Y, Zou F, Li R, Lu L, Chen S, Li Y, Hu Q, Lin Y, Zhang Y, He Z, Zhang X, Chen X, Peng T, Tang X, Cai W, Pan T, Li L, Zhang H. Liu B, et al. Among authors: lu l. J Clin Invest. 2021 Oct 1;131(19):e150211. doi: 10.1172/JCI150211. J Clin Invest. 2021. PMID: 34375315 Free PMC article. Clinical Trial.

2

Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.

Liu B, Zou F, Lu L, Chen C, He D, Zhang X, Tang X, Liu C, Li L, Zhang H. Liu B, et al. Among authors: lu l. J Virol. 2016 Oct 14;90(21):9712-9724. doi: 10.1128/JVI.00852-16. Print 2016 Nov 1. J Virol. 2016. PMID: 27535056 Free PMC article.

3

Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56.

Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, Liu W, Zhang Y, Lin Y, Jing S, Huang M, Huang B, Liu B, Zhang H. Zou F, et al. Among authors: lu l. Nat Commun. 2019 Sep 11;10(1):4109. doi: 10.1038/s41467-019-11893-4. Nat Commun. 2019. PMID: 31511513 Free PMC article.

4

Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef-AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells.

Liu B, Zhang X, Zhang W, Wu L, Jing S, Liu W, Xia B, Zou F, Lu L, Ma X, He D, Hu Q, Zhang Y, Deng K, Cai W, Tang X, Peng T, Zhang H, Li L. Liu B, et al. Among authors: lu l. Front Immunol. 2019 Sep 10;10:2151. doi: 10.3389/fimmu.2019.02151. eCollection 2019. Front Immunol. 2019. PMID: 31572371 Free PMC article.

5

Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins.

Qiao Y, Chen J, Wang X, Yan S, Tan J, Xia B, Chen Y, Lin K, Zou F, Liu B, He X, Zhang Y, Zhang X, Zhang H, Wu X, Lu L. Qiao Y, et al. Among authors: lu l. Cancer Commun (Lond). 2023 Jul;43(7):788-807. doi: 10.1002/cac2.12452. Epub 2023 Jun 6. Cancer Commun (Lond). 2023. PMID: 37282786 Free PMC article.

6

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.

Xia B, Lin K, Wang X, Chen F, Zhou M, Li Y, Lin Y, Qiao Y, Li R, Zhang W, He X, Zou F, Li L, Lu L, Chen C, Li W, Zhang H, Liu B. Xia B, et al. Among authors: lu l. Mol Ther Oncolytics. 2023 Jul 28;30:86-102. doi: 10.1016/j.omto.2023.07.007. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37593111 Free PMC article.

7

Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway.

Yu F, Chen Y, Zhou M, Liu L, Liu B, Liu J, Pan T, Luo Y, Zhang X, Ou H, Huang W, Lv X, Xi Z, Xiao R, Li W, Cao L, Ma X, Zhang J, Lu L, Zhang H. Yu F, et al. Among authors: lu l. Cell Death Discov. 2024 Jan 26;10(1):51. doi: 10.1038/s41420-024-01822-w. Cell Death Discov. 2024. PMID: 38272890 Free PMC article.

8

Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.

Lin K, Xia B, Wang X, He X, Zhou M, Lin Y, Qiao Y, Li R, Chen Q, Li Y, Feng J, Chen T, Chen C, Li X, Zhang H, Lu L, Liu B, Zhang X. Lin K, et al. Among authors: lu l. J Transl Med. 2024 Apr 12;22(1):349. doi: 10.1186/s12967-024-05159-x. J Transl Med. 2024. PMID: 38610029 Free PMC article.

9

Hodgkin lymphoma involving the tonsil misdiagnosed as tonsillar carcinoma: A case report and review of the literature.

Qin Y, Lu L, Lu Y, Yang K. Qin Y, et al. Among authors: lu y, lu l. Medicine (Baltimore). 2018 Feb;97(7):e9761. doi: 10.1097/MD.0000000000009761. Medicine (Baltimore). 2018. PMID: 29443738 Free PMC article. Review.

10

Nanoparticles Observed in a Shear Fracture of Dolomite and a Probable Formation Mechanism.

Li J, Cai Z, Huang Q, Shao T, Song M, Xiao Y, Lu L. Li J, et al. Among authors: lu l. J Nanosci Nanotechnol. 2021 Jan 1;21(1):555-566. doi: 10.1166/jnn.2021.18457. J Nanosci Nanotechnol. 2021. PMID: 33213654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,865 results

Search Page